Skip to main content
. 2019 Apr 5;19(6):4761–4769. doi: 10.3892/mmr.2019.10134

Figure 3.

Figure 3.

Figure 3.

Association between CKS2 mRNA expression and clinical features in patients with breast cancer. (A) ER status; (B) PR status; (C) HER2 status; (D) nodal status; (E) basal-like status; and (F) TNBC. ER, estrogen receptor; PR, progesterone receptor; HER2, erb-b2 receptor tyrosine kinase 2; TNBC, triple negative breast cancer; N, node; CKS2, cyclin dependent kinases regulatory subunit 2.